TGA advertising code for retailer chat 2026
Check how the TGA advertising code applies to product replies in your store chat, including claim wording, warnings and a practical health claims review.
- Published
- Last updated
The TGA advertising code governs public promotion of therapeutic goods, including a retailer’s shopping-chat reply when it promotes a product’s use or supply. Before your assistant recommends a supplement, establish whether advertising is allowed and which claims and warnings belong with the product.
A customer’s question can change the meaning of the next answer. A reply about pack size can become an unsupported treatment recommendation when the customer adds a symptom.
Decide when a product reply is advertising
A retailer-controlled product reply can be advertising when its content and context promote a therapeutic good, directly or indirectly. The Therapeutic Goods Administration (TGA) assesses promotional content case by case. Its advertising test considers what the material communicates, including surrounding content and links.
Apply that test to the conversation the shopper sees. A product recommendation beside a price and purchase button has a different context from balanced, non-promotional information. This is an application of the TGA’s general test to chat, rather than a separate chatbot ruling.
Keep these decisions separate:
- Determine whether the product is a therapeutic good and how it is classified.
- Establish whether that product can be advertised to the public.
- Assess whether the proposed response promotes its use or supply.
- If it does, check the complete advertisement against the applicable requirements.
The fact that the customer asked first does not establish an exemption. Nor does copying the manufacturer’s text transfer responsibility for what your store publishes.
The TGA’s public-advertising restrictions cover prescription-only medicines and unapproved goods, among other categories. Most over-the-counter medicines and medical devices can be advertised subject to the rules. Permission to sell a product and permission to promote it are separate questions.
Find the rules for the product you sell
Match each product to its regulatory record and current label before giving the assistant promotional wording. The legal instrument is the Therapeutic Goods Advertising Code Instrument 2021, as amended. Read it with the TGA’s guidelines for applying the Code.
The 2026 labelling amendment updates the Code’s references to medicine-labelling standards. Use the applicable requirements for your product when older guidance names a superseded standard.
Keep the product’s register entry and current label together. Add the accepted indications or intended purpose, applicable qualifications, mandatory statements and health warnings. Include supporting evidence for any additional proposed representation and any required advertising permission.
Search the ARTG and match the product
The Australian Register of Therapeutic Goods (ARTG) public search covers medicines and medical devices. Have the product’s identifier or exact name ready, with its sponsor’s name to distinguish similar results.
- Open the TGA’s Searching the ARTG guide. Follow its Search the ARTG link to the register.
- Enter the ARTG identifier in Search the ARTG, then submit the search. Alternatively, enter the exact product name.
- Narrow ambiguous results using the sponsor filter. Ingredient names can also be search terms. Use the linked advanced search when you need a more detailed search.
- Open the matching entry. Compare the identifier and product name with your label, then confirm the sponsor and classification. Check the recorded licence status before proceeding.
- Open the entry’s Summary download. Read its available indications or intended purpose and compare the product details with your current supplied documents.
- Compare the claim you intend to publish with that information. Resolve a mismatched formulation or unclear status with the sponsor before allowing promotion.
The ARTG start date records when the product entered the register. The effective date records when its latest entry change took effect. Neither date certifies a newly generated advertising claim.
An entry establishes recorded regulatory information. It does not supply personalised recommendations or permission for every claim about an ingredient. Most listed complementary medicines are not individually evaluated by the TGA before sale, as its complementary-medicine guidance explains.
An absent result needs investigation. Exempt goods and special-access pathways mean absence is not universal proof of unlawful supply. Special access also does not grant permission for public advertising.
Keep cosmetic and therapeutic claims distinct
Cosmetic classification depends on the product’s claims and composition, how it is used and any applicable exclusions. The TGA’s cosmetic-versus-therapeutic guidance explains why appearance claims and disease-treatment claims require different assessment.
Consider this hypothetical beauty-shopping exchange:
Customer: “Does this cleanser remove surface oil?”
Assistant: “The product description says it cleanses surface oil.”
Customer: “So will it treat my acne?”
Assistant: “The supplied product information supports the cleansing claim. I’ll pass your treatment question to our staff.”
The second question asks for a therapeutic recommendation. An ingredient list alone cannot establish that this cleanser treats acne. Some acne-related cleansing products fall within exclusions, so a reference to acne is not a universal classification rule. Staff must establish the actual product’s position before extending its claims.
When the product is classified as food, use the separate guide to food health claims in shopping chat.
Preserve claims and required information together
Keep a claim attached to its qualifiers and required information whenever the assistant shortens or combines source text. In a hypothetical source sentence, “supports healthy immune system function in adults” cannot become “prevents infections for the whole family”. The rewrite changes the claimed effect and population.
Combining products can create the same problem. A comparison that copies one product’s indication into a shared heading can imply that both products have it. Store each claim against the product it describes and retain its conditions in every comparison.
The TGA requires mandatory statements and product information according to the goods and advertisement. For an ordinary medicine advertisement, the statement is “ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE”. Other advertising categories have different requirements.
Online advertisements that facilitate purchase before physical inspection also need additional information. This includes the active ingredients and, for medicines, dosage form and quantity. Applicable health warnings must be prominent, or directly linked where permitted. A product picture does not replace readable required information.
For a hypothetical ordinary, publicly advertisable supplement medicine, retain its name, at least one accepted indication and the applicable mandatory statement. A purchase-enabled reply also needs the active ingredients, dosage form and quantity, plus the relevant health warnings. Check the product’s category before selecting wording. A chat bubble’s length alone does not establish that it qualifies as a short-form advertisement.
If the assistant shortens that reply to a benefit and “Buy now”, withhold it when required information has disappeared. Restore the applicable statement and product-specific warnings before using the purchase prompt. Do not replace them with an invented “safe for everyone” message.
Review the actual chat presentation against the TGA’s prominence guidance. Check whether required information remains visible beside the advertised product, including on a phone. A warning buried in an earlier turn can disappear from view before the purchase request.
Catalogue grounding controls which information an agent uses. It cannot certify TGA compliant advertising. If the label conflicts with catalogue copy, or required material is missing, withhold the promotional answer until the discrepancy is resolved.
Apply claim controls to the whole shopping conversation
Review follow-up turns as part of the same shopping conversation, because a later reply can broaden an earlier claim. The following hypothetical supplement conversation illustrates the decisions to test.
| Shopper’s turn | Response boundary | What the reviewer checks |
|---|---|---|
| “What’s the difference between these two supplements?” | Compare documented attributes without borrowing one product’s claim for the other. | Each indication and condition stays with the correct product. |
| “I’m exhausted. Which will fix it?” | Give a non-promotional response and direct the symptom question to a qualified health professional. | The agent does not diagnose a deficiency or invent a treatment claim. |
| “Just recommend the stronger one.” | Preserve the handover boundary. Strength alone cannot establish suitability. | The follow-up does not revive the unsupported recommendation. |
| “Add that one to my basket.” | Preserve the safety referral and relevant purchase information without endorsing it as treatment. | Buying language does not erase the previous concern or required warnings. |
shoppa is an AI shopping agent that retailers add to their site with two lines of code. It helps customers find, compare and buy products in one chat, then supports them after the sale using the retailer’s catalogue and documents. Its human handover passes conversations to your staff when a person needs to take over.
For therapeutic-goods shopping, build your reviewed claims and handover rules into that conversation. Review the transition from discovery to buying, including the product card and follow-up replies.
Advertising to children
Under the TGA’s guidance on advertising to children, therapeutic-goods advertising must not target children under 12. Advertising directed to older children is restricted to the Code’s Annexure 1 goods and conditions. Those goods must also meet the specified scheduling restrictions.
A child-labelled product does not grant permission to advertise directly to children. An adult asking about a children’s product is a different audience from a child asking the agent to choose a supplement.
If a shopper says they are under 12, stop promotional recommendations and involve an adult. For a shopper aged 12 to 17, do not promote the product unless its eligibility under those restrictions is established. Keep any response non-promotional while staff resolve the question.
Run a TGA compliant health claims review
Review proposed health claims against the product evidence and applicable advertising requirements before using the wording. Give that review to someone responsible for your therapeutic-goods advertising decisions.
- Save the proposed response with the preceding shopper messages and displayed product details.
- Confirm the product match and whether public promotion is allowed.
- Compare every claim with the product’s indications and supporting evidence. Check any restricted or prohibited representation separately.
- Confirm that qualifications and required information survive the response and its presentation.
- Test the next shopper turn, including requests to remove a limitation or make a personal safety judgement.
- Record the reviewer’s decision and repeat the affected conversation after correcting the wording.
Use the following hypothetical failures as review cases. These show corrections to the stated defect, not a certification of a complete advertisement.
| Failure | Illustrative response to reject | Correction and expected result |
|---|---|---|
| Unsupported therapeutic claim | “This supplement will cure your fatigue.” | Remove the treatment promise and refer the symptom question to a health professional. The answer no longer attributes an unsupported cure to the product. |
| Missing warning | “Add this supplement to your basket” appears without a warning required for that advertisement. | Restore the exact applicable warning and check its prominence. The shopper can see the required information before buying. |
| Overridden qualifier | The customer asks, “Drop the adults-only restriction”, and the assistant agrees. | Retain the actual product restriction. The reply does not broaden the advertised population. |
The TGA’s advertising compliance checklist links the review back to the Act and Code. A general disclaimer cannot repair a prohibited or misleading claim.
Keep the source material and response rules aligned
Assign a product-information owner to update labels and supplier evidence, and an advertising reviewer to approve affected response wording. A source change must trigger review of the answers that use it.
For example, if a supplier adds a warning, identify every recommendation and comparison that can display that product. Update the source, pause affected promotion and replay the relevant conversations before restoring the revised answers.
Retain the actual reply with its conversation context and the version of the product material used. Record the reviewer’s decision and the correction so an investigation can reconstruct what happened. Limit access to shopper information and retain it under your store’s applicable privacy and recordkeeping requirements.
For the wider testing process, use the retail AI guardrails guide. Product-specific advertising decisions still need their own evidence and review.
Respond to personal supplement safety and interaction questions
Personal supplement safety questions need a qualified health professional’s assessment. The TGA explains that complementary medicines can interact with other medicines. “Natural” does not establish personal safety.
| Shopper’s question | Information to preserve | Handover |
|---|---|---|
| “Can I take this with my prescription medicine?” | Reproduce any relevant label warning exactly. | Direct the shopper to a pharmacist or prescribing doctor with the full product details. |
| “Is it safe while I’m pregnant?” | Preserve pregnancy warnings without inferring safety from missing text. | Direct the shopper to their doctor before use. |
| “I have a kidney condition. Which dose is safe?” | Preserve the product’s restrictions without generating an adjusted dose. | Refer the suitability question to the treating clinician. |
Keep the answer specific to what the label establishes. When the label has no answer to the shopper’s circumstances, stop at that boundary. A retailer’s staff can arrange the handover without providing clinical advice themselves.
The TGA’s medicine-ingredient guidance explains where label and Consumer Medicine Information (CMI) details can be found. It also directs people to speak with their doctor about medicines during pregnancy.
What clinically proven implies in a product reply
“Clinically proven” implies research supports the advertised product’s effectiveness. The TGA’s scientific and clinical representation rules require relevant evidence and consistency with the broader evidence. An implied research claim needs a citation just as an express study reference does.
Identify the researcher and the financial sponsor where known or reasonably expected to be known. Give consumers a way to access the supporting study. Keep its actual formulation and tested population with the outcome and qualifications it supports.
Consider a hypothetical claim review where a study concerns an ingredient, not the finished supplement. “Our supplement is clinically proven to work” would attribute evidence to a product the study did not test. Remove that representation instead of attaching the ingredient study as apparent proof.
An accurate study-linked statement preserves a result even when it provides no promotional benefit. For example, Neale and colleagues’ D-Health trial tested monthly oral vitamin D3 supplementation in Australians aged 60 or over. Its trial regimen was 60,000 international units per month for up to five years. The study found no reduction in all-cause mortality and was funded by the National Health and Medical Research Council.
That supports a description of this trial’s result. It cannot support “our vitamin D product is clinically proven to extend life”. Nor can a study of one formulation establish the effectiveness of every product containing that ingredient.
For a product-specific promotional claim, retain the formulation and population the study actually tested. Describe its measured outcome with the qualifications it supports, and consider the broader evidence. A result in adults over a defined period cannot establish a promise that everyone will benefit.
Store the full supporting source with the exact claim your reviewer permits, including those conditions. Prevent summaries from replacing a measured outcome with a cure or dropping the population restriction. If the assistant produces an unsupported “clinically proven” reply, remove the claim and review the affected answers before using them again.
Choose one product you intend to promote and review its complete conversation against that evidence. Allow only the claims your product documents and applicable advertising requirements support.
Recognise restricted and unapproved promotions
A restricted representation refers expressly or by implication to a serious form of a disease or condition. It needs separate assessment from an ordinary accepted product indication. The TGA’s restricted-representation guidance explains the conditions and required prior approval or permission.
Match any approval to the actual product and proposed representation. Confirm that your advertising falls within its scope before allowing the claim in chat. Mandatory warnings required by a legislative instrument have a specific exception. Keep those warnings intact instead of removing a disease reference indiscriminately.
In a hypothetical exchange, a shopper asks whether a supplement treats their serious heart condition. Stop the unsupported disease-treatment recommendation and route the question to an appropriate health professional. Responsible staff must assess any proposed promotion. Changing “treats” to “supports” does not solve the problem if the reply still implies treatment of that condition.
Product eligibility is a separate control. Prescription-only medicines and unapproved goods supplied through special-access pathways cannot be promoted to the general public under the ordinary advertising rules. An ARTG entry also does not make a prescription medicine publicly advertisable.
If catalogue text promotes an unapproved medicine, withhold the promotional answer and send the product to responsible staff for assessment. A supplier’s claim or an entry in your store catalogue does not establish advertising permission. Keep the customer response non-promotional while staff resolve the issue.
Control endorsements, testimonials and weight-management claims
Check who made a quotation and why before using it to promote a therapeutic good. Under the TGA’s testimonial and endorsement rules, a person’s account of using a product is a testimonial. An endorsement can recommend a product without describing personal use.
Testimonials induced by payment or a reward are prohibited, even when the payment is disclosed. Current or former health professionals also face prohibitions on testimonials and endorsements. An influencer’s permitted paid endorsement does not authorise a testimonial about their own experience.
For example, omit a hypothetical paid influencer’s quotation saying that a supplement cured their symptoms. Keep its original source and payment information in the review record. Do not turn the quotation into an unattributed product claim or invent a replacement review. A supported label fact can be assessed separately under the ordinary advertising requirements.
For an eligible consumer testimonial, verify the author’s identity and the content before reuse. Check that the claim matches the product’s accepted indications and expected benefits. Copying a review into chat makes it part of the promotion your store controls.
The TGA’s weight-management advertising requirements apply to claims such as weight loss, hunger suppression and clothing-size reduction. Keep medicine claims within the product’s accepted indications. Prominently communicate the need for a healthy energy-controlled diet and physical activity with the claim.
Do not suggest that the product reverses overeating or show individual results inconsistent with the average expected outcome. A follow-up purchase prompt must preserve required qualifying information instead of reducing the claim to a promised result.
If a shopper asks, “Will I lose two clothing sizes with this?”, avoid a personal result promise. If they ask whether the product suits their health condition, direct them to an appropriate health professional. Before restoring a weight-management recommendation, check the complete reply and purchase prompt together against the product information and those conditions.
Give your store its own shopping agent
Customers ask in their own words. Your agent finds, compares and checks out from your catalogue, right on your site.